Genome-wide association study of REM sleep behavior disorder in Parkinson's disease
Sosero, Y. L.; Heilbron, K.; Fontanillas, P.; Norcliffe-Kaufmann, L.; Yu, E.; Rudakou, U.; Ruskey, J. A.; Freeman, K.; Asayesh, F.; Brolin, K.; Swanberg, M.; Morris, H. R.; Wu, L.; Real, R.; Pihlstrom, L.; Tan, M.; Gasser, T.; Brockmann, K.; Liu, H.; Hu, M. T. M.; Grosset, D. G.; Lewis, S. J. G.; Kwok, J. B.; Pastor, P.; Alvarez, I.; Skorvanek, M.; Lackova, A.; Ostrozovicova, M.; Rizig, M.; The International Parkinson?s Disease Genomics Consortium, ; 23andMe Research Team, ; Krohn, L.; Gan-Or, Z.
Show abstract
ObjectiveREM sleep behavior disorder (RBD) is a prodromal synucleinopathy, reported in a subset of Parkinsons disease (PD) patients, and associated with neuropsychiatric symptoms in PD. We aimed to compare the genetic background of PD patients with probable RBD (PD+RBD) and PD patients without probable RBD (PD-RBD). Furthermore, we examined genetic correlations and potential causal associations between multiple neuropsychiatric traits and PD+RBD. MethodsWe performed a genome-wide association study (GWAS) including 5,403 PD+RBD and 13,020 PD-RBD. To test for genetic correlations and potential causal associations between neuropsychiatric traits and PD+RBD, we used linkage disequilibrium score regression and Mendelian randomization. ResultsThe SNCA locus was associated with PD+RBD compared to PD-RBD (rs10005233, OR=1.21, 95% CI=1.16-1.27, p=1.81e-15). Further examination of known genetic loci associated with PD from the most recent PD GWAS in Europeans and Asians identified additional variants associated with reduced risk for PD+RBD: two in the SNCA locus (rs5019538-G, OR=0.85, 95% CI=0.81-0.89, p=2.46E-10; rs356182-G, OR=0.89, 95% CI=0.84-0.95, p=0.0001), and one in the LRRK2 locus (rs34637584, p.G2019S, OR=0.41, 95% CI=0.28-0.61, p=1.04E-5). We found a potential genetic correlation between attention deficit hyperactivity disorder (ADHD) and PD+RBD, which was not statistically significant after correction for multiple comparisons. No causative association emerged between PD and neuropsychiatric traits. InterpretationGenetic variants contribute to the occurrence of RBD in PD, further distinguishing between the PD+RBD and PD-RBD subtypes. Understanding the mechanisms underlying these genetic associations could contribute to the development of subtype-specific treatments.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetic Analysis and Natural History of Parkinson’s Disease Due to the LRRK2 G2019S Variant 98%
- Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations 97%
- Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s disease 97%
Similar papers in this journal
Similar papers in this journal
- Dopamine pathway and Parkinson’s risk variants are associated with levodopa-induced dyskinesia 98%
- Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease 96%
- Penetrance of Parkinson’s disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.